Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, Fasano A. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes 2019; 10(3): 189-199 [PMID: 30891154 DOI: 10.4239/wjd.v10.i3.189]
Corresponding Author of This Article
Maureen M Leonard, MD, MSc, Instructor, Clinical Director, Department of Pediatric Gastroenterology, Mass General Hospital for Children, 55 Fruit Street (Jackson 14), Boston, MA 02114, United States. mleonard7@mgh.harvard.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Diabetes. Mar 15, 2019; 10(3): 189-199 Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.189
Table 1 Demographic data: Participants with type 1 diabetes and their first-degree relatives n (%)
Demographics
T1D only (n = 280)
T1D + CD (n = 22)
FDR only (n = 689)
FDR +CDA (n = 36)
White
249 (88.9)
22 (100)
629 (91.3)
35 (97.2)
Not hispanic
188 (67.1)
15 (68.2)
451 (65.5)
27 (75.0)
Female
178 (63.6)
17 (77.3)
409 (59.4)
26 (72.2)
Age at screening (yr), median (range)
19 (2-72)
14.5 (7-43)
40 (1-74)
39.5 (3-55)
Age at diagnosis of T1D (yr), median (range)
10 (0.1-64)
6.5 (1-21)
Presence of gastrointestinal symptoms (GI sx)
113 (40.5)
6 (27.3)
216 (31.4)
13 (36.1)
Presence of extraintestinal symptoms (Ex sx)
78 (27.9)
3 (13.6)
176 (25.5)
7 (19.4)
Both GI and Ex symptoms
56 (20)
3 (13.6)
98 (14.2)
4 (11.1)
Asymptomatic
144 (51.6)
16 (72.7)
394 (57.3)
20 (55.6)
Human leukocyte antigen (HLA) genotype
DR3-DQ2
49 (18)
2 (9.1)
148 (21.8)
10 (28.6)
DR3-DQ2 homozygote
18 (6.6)
3 (13.6)
25 (3.7)
3 (8.6)
DR7-DQ2
12 (4.4)
1 (4.6)
41 (6.1)
2 (5.7)
DR7-DQ2 homozygote
2 (0.7)
0 (0)
13 (1.9)
0 (0)
DR3/DR7-DQ2 homozygote
1 (0.37)
0 (0)
20 3.0)
3 (8.6)
DR4-DQ8
83 (30.5)
5 (22.7)
205 (30.2)
10 (28.6)
DR3-DQ2/DR4-DQ8
70 (25.7)
7 (31.8)
50 (7.4)
6 (17.1)
DR7-DQ2/DR4-DQ8
6 (2.2)
4 (18.2)
33 (4.9)
0 (0)
DQ2/DQ8 negative
31 (11.4)
0 (0)
142 (20.9)
1 (2.9)
Haptoglobin genotype (HP) (Zonulin)
HP 1-1
46 (16.4)
2 (9.1)
120 (17.4)
8 (22.2)
HP 2-1
118 (42.1)
10 (45.5)
278 (40.4)
21 (58.3)
HP 2-2
116 (41.4)
10 (45.5)
290 (42.2)
7 (19.4)
Any HP2
234 (83.6)
20 (90.9)
568 (82.6)
28 (77.7)
Table 2 Cohort prevalence of celiac disease and celiac disease autoimmunity
n
CD
CDA
CD at screening
CDA at screening
CDA prevalence estimation
Type 1 diabetes
302
8 (2.7)
3 (1.0)
8 (2.5)
3 (0.7)
22 (7.3)
First-degree relative
725
9 (1.2)
4 (0.6)
18 (2.7)
5 (1.0)
36 (5.0)
Table 3 Univariate and multiple regression models: Factors related to celiac disease autoimmunity in participants with type 1 diabetes
Estimate
Se
Lower limit
Upper limit
Z stat
P-value
Univariate Model (exchangeable correlation)
Female
0.6562
0.5151
-0.3534
1.6659
1.27
0.2027
Age
-0.0314
0.0152
-0.0611
-0.0017
-2.07
0.0383A
Onset of T1D
-0.0658
0.0342
-0.1329
0.0013
-1.92
0.0546
Gastrointestinal (GI) symptoms
-0.5812
0.491
-1.5435
0.3811
-1.18
0.2365
Extraintestinal (EX) symptoms
-0.9204
0.6391
-2.1731
0.3323
-1.44
0.1498
Both GI and EX symptoms
-0.4724
0.6385
-1.7239
0.7791
-0.74
0.4594
No GI or EX symptoms
0.9074
0.4931
-0.059
1.8737
1.84
0.0657
Human Leukocyte Antigen (HLA) DQ2-DR3 Heterozygous
-0.7402
0.7571
-2.2241
0.7437
-0.98
0.3282
HLA DQ2-DR3 Homozygous
0.7843
0.67
-0.5332
2.1019
1.17
0.2433
HLA DQ2-DR7 Heterozygous
0.028
1.0649
-2.0592
2.1152
0.03
0.979
HLA DQ8
-0.3975
0.5234
-1.4233
0.6283
-0.76
0.4475
HLA DQ2-DR3/DQ8
0.2767
0.4814
-0.6668
1.2203
0.57
0.5654
HLA DQ2-DR7/DQ8
2.4851
0.6507
1.2098
3.7604
3.82
0.0001B
HLA DQ2 Heterozygous
-0.575
0.6367
-1.823
0.6729
-0.9
0.3665
HLA DQ2 Homozygous
0.6192
0.666
-0.6862
1.9246
0.93
0.3525
Haptoglobin genotype (HP) 1-1
-0.6932
0.7671
-2.1967
0.8104
-0.9
0.3662
HP 2-1
0.1539
0.4414
-0.7112
1.0191
0.35
0.7273
HP 2-2
0.1525
0.4422
-0.7141
1.0192
0.34
0.7301
Any HP2
0.693
0.767
-0.81
2.197
0.9
0.366
First degree relative (FDR) with celiac disease (CD)
1.4091
0.6188
0.1962
2.622
2.28
0.0228C
FDR with Type 1 diabetes (T1D)
0.0724
0.557
-1.0193
1.1641
0.13
0.8966
FDR with thyroid disease
0.7839
0.4619
-0.1215
1.6892
1.7
0.0897
FDR with other autoimmune disease
1.1634
0.4432
0.2947
2.0321
2.62
0.0087D
CD in another relative
0.4136
0.6598
-0.8796
1.7068
0.63
0.5307
Multiple Regression Model (independence working correlation)
Intercept
-3.3213
0.927
-5.1383
-1.5043
-3.58
0.0003
Age
-0.0121
0.019
-0.0494
0.0252
-0.64
0.5246
Onset of T1D
-0.0396
0.0425
-0.1229
0.0436
-0.93
0.3509
DQ2-DR7/DQ8
2.4131
0.8401
0.7666
4.0596
2.87
0.0041E
No GI or EX symptoms
1.1905
0.6566
-0.0963
2.4774
1.81
0.0698
FDR with CD
0.6927
1.3443
-1.9421
3.3274
0.52
0.6064
FDR with thyroid disease
-0.8976
1.6214
-4.0756
2.2804
-0.55
0.5799
FDR with other autoimmune disease
1.9765
1.7861
-1.5241
5.4771
1.11
0.2685
Table 4 Univariate and multiple regression models: Factors related to celiac disease autoimmunity in first degree relatives of participants with type 1 diabetes
Estimate
Se
Lower limit
Upper limit
Z stat
P-value
Univariate model (exchangeable correlation)
White
1.26
0.88
-0.47
2.98
1.43
0.154
Female
0.5433
0.3674
-0.1768
1.2635
1.48
0.1392
Age
-0.0046
0.0097
-0.0236
0.0144
-0.47
0.6355
Gastrointestinal (GI) symptoms
0.2551
0.3395
-0.4103
0.9206
0.75
0.4524
Extraintestinal (EX) symptoms
-0.3748
0.4596
-1.2756
0.526
-0.82
0.4148
Both GI and EX symptoms
-0.2715
0.5305
-1.3113
0.7682
-0.51
0.6087
No GI or EX symptoms
-0.085
0.3419
-0.7551
0.5851
-0.25
0.8036
Human Leukocyte Antigen (HLA) DQ2-DR3 Heterozygous
0.4255
0.383
-0.3251
1.1761
1.11
0.2666
HLA DQ2-DR3 Homozygous
0.8042
0.7654
-0.696
2.304
1.05
0.2934
HLA DQ2-DR7 Heterozygous
-0.0376
0.6636
-1.3382
1.263
-0.06
0.9548
HLA DQ2-DR3/DR7 Homozygous
1.02
0.715
-0.381
2.42
1.43
0.153
HLA DQ8
-0.0981
0.4058
-0.8934
0.6972
-0.24
0.809
HLA DQ2-DR3/DQ8
0.9272
0.472
0.0021
1.8523
1.96
0.0495A
HLA DQ2/DQ8 Negative
-2.1836
1.0232
-4.1891
-0.1781
-2.13
0.0328B
HLA DQ2 Heterozygous
0.3561
0.388
-0.4043
1.1166
0.92
0.3586
HLA DQ2 Homozygous
0.6842
0.5435
-0.3811
1.7495
1.26
0.2081
Haptoglobin genotype (HP) 1-1
0.2901
0.4341
-0.5607
1.1409
0.67
0.5039
HP 2-1
0.6823
0.3429
0.0103
1.3544
1.99
0.0466C
HP 2-2
-1.0763
0.4252
-1.9096
-0.2429
-2.53
0.0114D
Any HP2
-0.29
0.434
-1.141
0.561
-0.67
0.503
First degree relative (FDR) with CDceliac disease (CD)
1.6768
0.3809
0.9303
2.4233
4.4
<.0001E
FDR with thyroid disease
-0.503
0.4849
-1.4533
0.4473
-1.04
0.2995
FDR with other autoimmune disease
0.6817
0.3606
-0.025
1.3884
1.89
0.0587
CD in other relative
0.5217
0.7115
-0.8728
1.9161
0.73
0.4634
Multiple regression model (independence working correlation)
Intercept
-2.8829
0.404
-3.6746
-2.0912
-7.14
< 0.0001
HLA DQ2-DR3/DQ8
0.9407
0.5381
-0.1139
1.9953
1.75
0.0804
HLA DQ2/DQ8 Negative
-1.9348
1.0275
-3.9487
0.0791
-1.88
0.0597
HP 2-1
0.0804
0.4492
-0.8001
0.9609
0.18
0.858
HP 2-2
-1.0149
0.563
-2.1185
0.0886
-1.8
0.0715
FDR with CD
2.3635
0.7576
0.8787
3.8483
3.12
0.0018F
FDR with other autoimmune disease
-0.8269
0.7245
-2.2468
0.5932
-1.14
0.2538
Citation: Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, Fasano A. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes 2019; 10(3): 189-199